Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 076788
Company: TARO
Company: TARO
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
MOMETASONE FUROATE | MOMETASONE FUROATE | 0.1% | LOTION;TOPICAL | Prescription | AB | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
03/15/2006 | ORIG-1 | Approval |
Label is not available on this site. |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
03/22/2019 | SUPPL-10 | Labeling-Package Insert |
Label is not available on this site. |
||
03/02/2015 | SUPPL-7 | Labeling-Package Insert |
Label is not available on this site. |
MOMETASONE FUROATE
LOTION;TOPICAL; 0.1%
TE Code = AB
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
MOMETASONE FUROATE | MOMETASONE FUROATE | 0.1% | LOTION;TOPICAL | Prescription | No | AB | 075919 | FOUGERA PHARMS |
MOMETASONE FUROATE | MOMETASONE FUROATE | 0.1% | LOTION;TOPICAL | Prescription | No | AB | 090506 | GLENMARK PHARMS LTD |
MOMETASONE FUROATE | MOMETASONE FUROATE | 0.1% | LOTION;TOPICAL | Prescription | No | AB | 077180 | PADAGIS ISRAEL |
MOMETASONE FUROATE | MOMETASONE FUROATE | 0.1% | LOTION;TOPICAL | Prescription | No | AB | 076788 | TARO |